The management of postoperative recurrence of non-small cell lung cancer harboring epidermal growth factor receptor (EGFR) mutation: what is the best way?
J Thorac Dis
.
2022 Apr;14(4):812-815.
doi: 10.21037/jtd-22-97.
Authors
Hiroyuki Adachi
1
,
Yuichi Saito
2
Affiliations
1
Department of Thoracic Surgery, Kanagawa Cancer Center, Yokohama, Japan.
2
Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan.
PMID:
35572906
PMCID:
PMC9096306
DOI:
10.21037/jtd-22-97
No abstract available
Publication types
Editorial
Comment